BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30553450)

  • 1. IL-17A modulates osteoclast precursors' apoptosis through autophagy-TRAF3 signaling during osteoclastogenesis.
    Xue Y; Liang Z; Fu X; Wang T; Xie Q; Ke D
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1088-1092. PubMed ID: 30553450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy mediated by JNK1 resists apoptosis through TRAF3 degradation in osteoclastogenesis.
    Ke D; Zhu Y; Zheng W; Fu X; Chen J; Han J
    Biochimie; 2019 Dec; 167():217-227. PubMed ID: 31654668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A regulates the autophagic activity of osteoclast precursors through RANKL-JNK1 signaling during osteoclastogenesis in vitro.
    Ke D; Fu X; Xue Y; Wu H; Zhang Y; Chen X; Hou J
    Biochem Biophys Res Commun; 2018 Mar; 497(3):890-896. PubMed ID: 29476739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway.
    Tang H; Zhu S; Chen K; Yuan S; Hu J; Wang H
    PLoS One; 2023; 18(2):e0281845. PubMed ID: 36795736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK1 regulates RANKL-induced osteoclastogenesis
    Ke D; Ji L; Wang Y; Fu X; Chen J; Wang F; Zhao D; Xue Y; Lan X; Hou J
    FASEB J; 2019 Oct; 33(10):11082-11095. PubMed ID: 31295022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A inhibits the degradation of RANKL in osteoblasts by inhibiting BCL2-Beclin1-autophagy signaling.
    Chen XX; Wu HJ; Ke DS; Zhu YR
    In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):300-311. PubMed ID: 37002492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17 promotes osteoclastogenesis and periodontal damage via autophagy in vitro and in vivo.
    Zhong J; Wang Z; Yuan W; Shen Y; Chen L
    Int Immunopharmacol; 2022 Jun; 107():108631. PubMed ID: 35219162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
    Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
    Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
    Ke D; Yu Y; Li C; Han J; Xu J
    Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation.
    Xiu Y; Xu H; Zhao C; Li J; Morita Y; Yao Z; Xing L; Boyce BF
    J Clin Invest; 2014 Jan; 124(1):297-310. PubMed ID: 24316970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Puerarin inhibits the osteoclastogenesis by inhibiting RANKL-dependent and -independent autophagic responses.
    Zhang G; Wang Y; Tang G; Ma Y
    BMC Complement Altern Med; 2019 Oct; 19(1):269. PubMed ID: 31615565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubiadin-1-methyl ether inhibits BECN1 transcription and Beclin1-dependent autophagy during osteoclastogenesis by inhibiting NF-κB p65 activation.
    Cai S; Chen Y; Chen J; Wei W; Pan J; Wu H
    Exp Biol Med (Maywood); 2023 Sep; 248(17):1518-1526. PubMed ID: 37750211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-17A deficiency inhibits lung cancer-induced osteoclastogenesis by promoting apoptosis of osteoclast precursor cells.
    Wang H; Tang H; Yuan S; Liang C; Li Y; Zhu S; Chen K
    PLoS One; 2024; 19(2):e0299028. PubMed ID: 38394046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane Inhibits Osteoclastogenesis via Suppression of the Autophagic Pathway.
    Luo T; Fu X; Liu Y; Ji Y; Shang Z
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33445451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways.
    Liao C; Cheng T; Wang S; Zhang C; Jin L; Yang Y
    Bone; 2017 Aug; 101():10-20. PubMed ID: 28414140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beclin 1 positively regulates osteoprotegerin-induced inhibition of osteoclastogenesis by increasing autophagy in vitro.
    Tong X; Min W; Li S; Chen M; Song R; Bian J; Gu J; Liu Z
    Differentiation; 2021; 121():35-43. PubMed ID: 34454349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy exerts pivotal roles in regulatory effects of 1α,25-(OH)
    Ji L; Gao J; Kong R; Gao Y; Ji X; Zhao D
    Biochem Biophys Res Commun; 2019 Apr; 511(4):869-874. PubMed ID: 30850163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A inhibits autophagic activity of HCC cells by inhibiting the degradation of Bcl2.
    Li S; Lin Z; Zheng W; Zheng L; Chen X; Yan Z; Cheng Z; Yan H; Zheng C; Guo P
    Biochem Biophys Res Commun; 2019 Jan; 509(1):194-200. PubMed ID: 30579601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway.
    Cai ZY; Yang B; Shi YX; Zhang WL; Liu F; Zhao W; Yang MW
    Biochem Biophys Res Commun; 2018 Sep; 503(2):428-435. PubMed ID: 29649480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen.
    Cheng L; Zhu Y; Ke D; Xie D
    Cell Prolif; 2020 Apr; 53(4):e12789. PubMed ID: 32157750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.